LSM14B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.601000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.032200E-01
Normal-vs-Stage2
7.996600E-01
Normal-vs-Stage3
3.965200E-01
Normal-vs-Stage4
3.481600E-01
Stage1-vs-Stage2
8.776400E-01
Stage1-vs-Stage3
1.648350E-01
Stage1-vs-Stage4
3.579000E-01
Stage2-vs-Stage3
1.619220E-01
Stage2-vs-Stage4
3.097200E-01
Stage3-vs-Stage4
1.166950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.262600E-01
Normal-vs-AfricanAmerican
7.453400E-01
Normal-vs-Asian
7.276400E-01
Caucasian-vs-AfricanAmerican
9.537400E-01
Caucasian-vs-Asian
1.805390E-01
AfricanAmerican-vs-Asian
4.199000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.853400E-01
Normal-vs-Female
8.692200E-01
Male-vs-Female
3.074200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.298800E-01
Normal-vs-Age(41-60Yrs)
5.204600E-01
Normal-vs-Age(61-80Yrs)
9.081800E-01
Normal-vs-Age(81-100Yrs)
7.579200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.965800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.144200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.833000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.386000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.216400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.743000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.894800E-01
Normal-vs-Daily Drinker
6.686400E-01
Normal-vs-Weekly Drinker
8.099200E-01
Normal-vs-Occasional Drinker
4.489400E-01
Normal-vs-Social Drinker
5.505200E-01
Non Drinker-vs-Daily Drinker
3.194200E-01
Non Drinker-vs-Weekly Drinker
6.836800E-01
Non Drinker-vs-Occasional Drinker
1.324160E-01
Non Drinker-vs-Social Drinker
1.970830E-01
Daily Drinker-vs-Weekly Drinker
6.348000E-01
Daily Drinker-vs-Occasional Drinker
7.047000E-01
Daily Drinker-vs-Social Drinker
7.491600E-01
Weekly Drinker-vs-Occasional Drinker
3.503600E-01
Weekly Drinker-vs-Social Drinker
4.399600E-01
Occasional Drinker-vs-Social Drinker
9.924000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.695800E-01
Normal-vs-Grade 2
9.994000E-01
Normal-vs-Grade 3
9.131200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.707600E-01
Grade 1-vs-Grade 3
4.536400E-01
Grade 1-vs-Grade 4
9.695800E-01
Grade 2-vs-Grade 3
6.916200E-02
Grade 2-vs-Grade 4
9.994000E-01
Grade 3-vs-Grade 4
9.131200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.162200E-01
Normal-vs-NonDiabetic
6.319400E-01
Diabetic-vs-NonDiabetic
1.002170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.123000E-01
Normal-vs-NoPancreatitis
7.626600E-01
Pancreatitis-vs-NoPancreatitis
8.488800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.324000E-01
Normal-vs-N1
8.010800E-01
N0-vs-N1
6.987600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.173000E-01
Normal-vs-TP53-NonMutant
7.008200E-01
TP53-Mutant-vs-TP53-NonMutant
3.134400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
